BioTime, LifeMap Acquiring XenneX | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioTime and its wholly owned subsidiary LifeMap Sciences announced today it is acquiring XenneX for an undisclosed amount.

XenneX will be merged into LifeMap. The deal is expected to close in 30 days.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.